March 9, 2017 9:00 am
China’s central government is laying plans to curb pollution, increase food and drug safety, and boost scientific research—though supporting details are scarce.
Chinese Premier Li Keqiang outlined these and other major goals during the opening session of the National People’s Congress on Sunday. The congress discussions are not likely to result in new legislation specific to science but speeches by top leaders set the tone for policy over the coming year.
“Having reached the current stage of development, China can now advance only through reform and innovation,” Li said in support of his call to boost research efforts. China has “the largest pool of scientists, engineers, and professionals in the world, and their potential for innovation is truly tremendous.”
March 1, 2017 9:00 am
Global funding for research on neglected diseases — which include tuberculosis, HIV/AIDS and malaria — is at its lowest level since 2007, according to the annual G-FINDER investment report by Policy Cures Research, a health-policy analysis firm in Sydney, Australia.
February 17, 2017 9:00 am
An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. Though not previously approved in the United States, the drug, deflazacort, has for years been available to patients suffering from the devastating and fatal disease Duchenne muscular dystrophy; families can import it from abroad for about $1,200 per year on average. The new list price for the drug? $89,000 a year.
February 9, 2017 9:00 am
A group backed by the Bill & Melinda Gates Foundation that works on India’s immunization program will now be funded by the health ministry, a government official said, a move in part prompted by fears foreign donors could influence policy making.
January 31, 2017 9:00 am
Clearly, private companies cannot be expected to invest on their own. But it is incumbent on governments to invest, and thus address this market failure, in partnership with pharma. It is therefore encouraging that there is now a solid plan to do just that: the Coalition for Epidemic Preparedness Innovations (CEPI), launched on 18 January at the World Economic Forum in Davos, Switzerland, aims to develop and take through early clinical trials vaccines against potential threats. It already has enough cash to work on three — MERS, Nipah-virus infection and Lassa fever.
January 25, 2017 9:00 am
The WHO lost a lot of trust in the aftermath of the 2014 Ebola outbreak in West Africa. Nabarro said his hope is to make sure that doesn’t happen again.
January 13, 2017 9:00 am
Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection. The vaccine is now being fast-tracked for regulatory approval.
December 20, 2016 9:00 am
Former U.S. Food and Drug Administration commissioner David A. Kessler has called the failure to recognize the dangers of painkillers one of the biggest mistakes in modern medicine.
December 15, 2016 9:00 am
The data are the first to quantify the risks to women infected at different times during pregnancy, and they seem to confirm that they are highest early in pregnancy.
December 14, 2016 9:00 am
Aleppo would go down in history as one of the great failures of the international community to halt human rights abuses.